Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch.
1. The effects of a purified micronized flavonoid fraction (S5682) on mean internal diameter and blood flow of arterioles and venules, as well as the functional capillary density (FCD) were evaluated in the hamster cheek pouch microvasculature before and after 90 min of total ischaemia. 2. Male hamsters were treated for ten days, twice a day, with oral doses of S5682 (5, 20, 80 and 160 mg kg-1 day-1) or placebo (10% lactose solution). The cheek pouch preparation was placed under an intravital microscope coupled to a closed circuit TV system. Local ischaemia was obtained by a cuff mounted around the neck of the everted pouch where it leaves the mouth of the hamster. 3. Measurements were performed before ischaemia, at the onset of reperfusion and 10, 20, 30, 45 and 60 min thereafter. Diameters were measured by means of an image shearing device. Red blood cell (RBC) velocity was analysed by use of the dual-slit photometric technique. Blood flow was calculated from diameters and RBC velocities. FCD, defined as the number of capillaries with flowing blood per field of observation, was also assessed. 4. During reperfusion, placebo-treated animals showed a significant vasodilatation, a decrease in blood flow and FCD and S5682-treated animals showed a clear trend, dose-dependent, towards maintaining these parameters closer to the value found before ischaemia. 5. In conclusion, our results indicate that S5682 improves the microvascular reactivity and FCD after ischaemia/reperfusion. These data suggest that S5682 could function as an antioxidant, which may explain its beneficial therapeutic effect in chronic venous insufficiency where oxidative stress is involved in the pathological mechanism.
Bouskela
E
E
Laboratório de Pesquisas em Microcirculação, Universidade do Estado do Rio de Janeiro, Brazil.
Cyrino
F Z
FZ
Lerond
L
L
D000284:Administration, Oral; D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000502:physiology; D002610:Cheek / Q000098:blood supply*; D006224:Cricetinae; D004145:Diosmin / Q000008:administration & dosage* / Q000494:pharmacology; D004338:Drug Combinations; D006569:Hesperidin / Q000008:administration & dosage* / Q000494:pharmacology; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D012039:Regional Blood Flow / Q000187:drug effects; D015424:Reperfusion; D014699:Venules / Q000187:drug effects / Q000502:physiology
D004338:Drug Combinations; C080675:S 5682; D004145:Diosmin; D006569:Hesperidin